Research Funding: MSD Oncology
Travel, Accommodations, Expenses: AstraZeneca, Bristol Myers Squibb
Giuseppe CuriglianoHonoraria: Ellipses Pharma
Consulting or Advisory Role: Roche, Genentech, Pfizer, Novartis, Eli Lilly, Foundation Medicine, Bristol Myers Squibb, Samsung, AstraZeneca, Daiichi Sankyo, Boehringer Ingelheim, GlaxoSmithKline, Seattle Genetics
Speakers’ Bureau: Roche, Genentech, Novartis, Pfizer, Eli Lilly, Foundation Medicine, Samsung, Daiichi Sankyo
Research Funding: Merck (Inst)
Travel, Accommodations, Expenses: Roche, Genentech, Pfizer
Evangelia D. RazisConsulting or Advisory Role: AstraZeneca, Bristol Myers Squibb, Pfizer
Research Funding: Novartis, Demo Pharmaceutical, Celldex, PAREXEL, Tesaro, Anabiosis Pharmaceuticals, Radius Health
Travel, Accommodations, Expenses: Genesis Pharmaceuticals, LEO Pharma, Roche, Genekor, Merck, Ipsen, Sanofi
Hassan ErrihaniConsulting or Advisory Role: Pfizer, Roche, MSD, Merck
Speakers’ Bureau: Novartis, Amgen
Research Funding: Roche
Travel, Accommodations, Expenses: Pierre Fabre (Inst), Merck (Inst)
Roselle B. De GuzmanHonoraria: Roche Oncology (Philippines), AstraZeneca, Novartis, Merck Serono, MSD Oncology, Boehringer Ingelheim
Consulting or Advisory Role: Roche, Novartis, Boehringer Ingelheim, AstraZeneca, Centus Biotherapeutics
Travel, Accommodations, Expenses: Hospira (Philippines), Roche (Philippines), Merck Sharp & Dohme, Eisai, Boehringer Ingelheim, AstraZeneca, Eli Lilly, Novartis
Christian RolfoConsulting or Advisory Role: Mylan, Archer Biosciences, Oncompass, Inivata, Merck Serono
Speakers’ Bureau: Novartis, MSD, Boehringer Ingelheim, Guardant Health, AstraZeneca
Research Funding: Lung Cancer Research Foundation, Pfizer
Travel, Accommodations, Expenses: AstraZeneca
Uncompensated Relationships: OncoDNA, Biomark, Guardant Health,
No other potential conflicts of interest were reported.
RetroSearch is an open source project built by @garambo | Open a GitHub Issue
Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo
HTML:
3.2
| Encoding:
UTF-8
| Version:
0.7.3